Coagulation disorders encompass a spectrum of inherited and acquired conditions that disrupt the delicate balance of haemostasis, leading to either excessive bleeding or thrombosis. Among these, ...

Blood coagulation factor XIII (FXIII) is the final transglutaminase in the clotting cascade, responsible for cross-linking fibrin polymers and stabilising the haemostatic plug. In plasma it circulates ...

Megakaryocytes, which are derived from hematopoietic stem cell precursors in bone marrow, form and release platelets; these circulate in the blood for 8 to 10 days before they are removed by hepatic ...

Blood clotting disorders can be inherited or acquired and lead to either excessive bleeding or too much clotting.

CRP, C-reactive protein; F, factor; IL-6, interleukin 6; NO, nitric oxide; PAI-1, plasminogen activator inhibitor-1; ROS, reactive oxygen species; TNF-α, tumor ...

Researchers at McMaster University have made a discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with ...

Hemophilia B, also known as Christmas disease, is a bleeding disorder. Its characteristic feature is a deficiency of clotting factor IX. This is a protein present in the blood that helps with ...

Clotting disorders can be treated by infusing patients with clotting proteins they lack, or with drugs that replace the function of these proteins. Gene therapies may soon become another option.